|
Office of Technology Transfer, University of Michigan: The
University of Michigan Office of Technology Transfer is
licensing intellectual property to OcuSciences for use in its
devices. The
Office of Technology Transfer is also providing various business
development services to assist OcuSciences in commercializing the
Retinal Metabolic Analysis (RMA) technology. Kellogg Eye Center, University of Michigan: The
Kellogg Eye Center will conduct clinical trials using RMA
technology to test the application of the technology on various retinal
diseases, including diabetes and age-related macular degeneration.
The first alpha-prototype will be housed in the photography department.
| 
